A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Condition(s):CholangiocarcinomaLast Updated:October 29, 2019Completed
Hide Studies Not Open or Pending
Condition(s):CholangiocarcinomaLast Updated:October 29, 2019Completed
Condition(s):Extrahepatic Bile Duct Cancer; Gallbladder CancerLast Updated:July 17, 2012Completed
Condition(s):CholangiocarcinomaLast Updated:October 3, 2018Completed
Condition(s):CholangiocarcinomaLast Updated:January 12, 2024Terminated
Condition(s):Cholangiocarcinoma; Liver Fluke-Related Cholangiocarcinoma; OpisthorchiasisLast Updated:March 15, 2024Not yet recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 6, 2024Not yet recruiting
Condition(s):CholangiocarcinomaLast Updated:March 21, 2024Recruiting
Condition(s):Unresectable Intrahepatic CholangiocarcinomaLast Updated:December 30, 2019Terminated
Condition(s):Extrahepatic Bile Duct Cancer; Gallbladder CancerLast Updated:September 12, 2017Completed
Condition(s):CholangiocarcinomaLast Updated:January 31, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.